Traditional Chinese medicine composition for curing tuberculous exadative pleurisy and preparation method thereof

Abstract

The invention provides a traditional Chinese medicine composition for curing tuberculous exadative pleurisy. The bulk drugs of the traditional Chinese medicine composition include flos farfarae, root bark of white mulberry, Chinese yam, euphorbia kansui, rhizoma panacis majoris, folium eriobotryae, radix stemonae, Chinese-date, inula flower, Chinese mahonia stems, rhizoma zingiberis, rhizoma sparganii, flowers carthami, folia perillae acutae, allium macrostemon, selaginella tamariscina, vine of multiflower knotweed, exocarpium, changium smyrnioides, poria cocos, semen coicis, turmeric, schisandra chinensis, semen lepidii, radix polygonati officinalis, rhizoma anemarrhenae, dayflower, polygonum cuspidatum, adenophora tetraphylla and kaladana. The traditional Chinese medicine composition reduces untoward effect of hydrothorax absorption, shortens course of disease, reduces pleural adhesions, pleural thickening and chest pain, enables hydrothorax absorption of patients to be quick, remarkably alleviates chest pain, and greatly reduces rate of pachynsis pleurae or pleural adhesion, thereby overcoming side effects caused by western drug therapy and having a certain curative effect on curing tuberculous exadative pleurisy.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating tuberculous exudative pleurisy and a preparation method thereof. Background technique [0002] Tuberculosis is still a preventable infectious disease with the highest morbidity and mortality worldwide. Tuberculous exudative pleurisy is the second most common form of extrapulmonary tuberculosis after lymph node tuberculosis. Tuberculous exudative pleurisy is the most common extrapulmonary tuberculosis. Exudative tuberculous exudative pleurisy is more common, and its incidence rate accounts for 54.8% of pleural effusions. [0003] Tuberculous exudative pleurisy is the process of inflammatory pathological changes such as hyperemia, exudation, necrosis, hyperplasia and fibrosis of the pleura after the body is infected with Mycobacterium tuberculosis. The exudative stage is dominated by pleural effusion, wh...

AI Technical Summary

Problems solved by technology

[0005] Conventional treatment methods for tuberculous exudative pleurisy mainly include anti-tuberculosis drugs, hormones, puncture and drainage, and / or pleural injection, etc. Oral administration of anti-tuberculosis drugs and hormones, combined with drainage of pleural effusion, can reduce pleural damage, Although the curative effect is acceptable, but the course of treatment is long and the effect is slow, it is easy to produce side effects such as pleural thickening, adhesion, and malabsorption of pleural effusion, and the recurrence rate is high. During treatment, the phagocytic function of macrophages is reduced, and the degradation of collagen fibers is reduced. As a result, fibrinogen, fibrinolytic activity, and collagenase activity are reduced, collagen formation is promoted, pleural hypertrophy, adhesions are accelerated, and even empyema develops, causing extensive pleural hypertrophy and lung atrophy, causing restrictive pulmonary ventilation barriers, so that some Patients are forced to take surgical treatment, and this treatment method is not easy to cure completely, easy to relapse or leave sequelae

Images